I've been tracking every dollar of my GLP-1 journey for the past 12 months and figured this community would appreciate the data. I started on brand Wegovy, switched to compounded semaglutide at month 5 due to cost, so I have direct comparison data.

Brand Wegovy (months 1-4):

• Retail price: $1,349.02/month
• My BCBS copay after PA: $275/month
• Savings card: did not qualify (employer plan exclusion)
• Total 4 months: $1,100
• Additional costs: $40 endo copay x2 visits = $80

Compounded Semaglutide (months 5-12):

• Telehealth provider subscription: $49/month
• Medication (compounded 5mg/2ml vial): $149/month
• Supplies (syringes, alcohol swabs): ~$8/month
• Total 8 months: $1,648

Full 12-month total: $2,828

If I'd stayed on brand Wegovy all 12 months at $275 copay, it would've been $3,300 + $160 in copays = $3,460. So compounded saved me about $632 over the year, PLUS I didn't have to deal with PA renewals and pharmacy games.

Results-wise? Lost 47 lbs on brand (months 1-4 on titration), lost 29 lbs on compounded (months 5-12 on maintenance dose). Total: 76 lbs. Both worked for me.

Love the detailed tracking. Let me add some context with broader pricing data I've compiled:

Average monthly costs across the community (2025-2026 data):

Your numbers are right in line with what I see. The sweet spot for cost-effectiveness is usually: brand + good insurance + savings card ($25/mo) > compounded ($100-200/mo) > brand with mediocre insurance ($200-500/mo) > brand cash pay ($1,000+/mo).

Pharmacist perspective: the cost comparison is valid but I want to flag a few things people should consider beyond just price:

1. Quality assurance: Brand medications go through FDA manufacturing inspections and batch testing. Compounding pharmacies are regulated by state boards and (if they're 503B outsourcing facilities) by FDA, but the oversight level is different.
2. Dosing precision: Brand pens deliver exact doses. With compounded vials + syringes, there's room for user error. Not a dealbreaker, but something to be aware of.
3. Continuity of supply: Brand has had shortage issues. Compounded has had regulatory uncertainty. Neither is perfectly reliable.
4. Insurance integration: Brand purchases count toward your deductible and OOP max. Compounded cash-pay does not. If you have other health expenses, this matters.

None of this means compounded is bad — I have patients on both who do great. Just make sure you're comparing apples to apples when doing the math.

My breakdown is different because I have Kaiser, which has its own pharmacy:

• Kaiser covers Wegovy with PA: $35 copay per 28-day supply
• Annual cost: $420 in copays + $0 for the three required appointments (covered by my plan)
• Total 12-month cost: $420

Kaiser is sometimes the butt of jokes but for GLP-1 coverage, they've been fantastic. They have an internal weight management program, the PA was approved in 3 days, and refills are automatic through their mail-order pharmacy.

If anyone is considering Kaiser during open enrollment — their GLP-1 coverage is genuinely one of the best I've seen, at least in California.

Jen — great points about the deductible. I actually hadn't thought about that. My BCBS plan has a $3,000 deductible, and the Wegovy copays were counting toward it. Now that I'm on compounded, I'm paying cash and nothing counts toward my deductible.

For someone with a lot of other health expenses, staying on brand could make sense from a total-cost-of-healthcare perspective. For me, GLP-1 is basically my only significant health expense, so the deductible point is less relevant.

Tina — $420/year is incredible. That's basically the best-case scenario for anyone with insurance. Jealous!